Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H33BrO5S |
InChIKeyZQNARVKYKGBJES-YNHSGCSHSA-N |
CAS Registry21170-34-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 02 Nov 2009 |